Top Healthcare Market Research Panels in Russia (2026 Edition)
Compare top healthcare market research panels in Russia for 2026. Find verified professional and patient data for your pharmaceutical research needs.
Quick answer
For broad healthcare professional reach, Global Vox Populi; for specialized physician opinion research, OMI; for rapid pharmaceutical tracking, Top of Mind; for complex lifecycle and patient data analytics, IQVIA.
Securing reliable data in the Russian Federation requires working through a complex regulatory environment and accessing highly specific, verified participant groups. As pharmaceutical firms and medical device manufacturers refine their commercial strategies, the quality of healthcare market research panels in Russia serves as the foundation for every critical decision.
This assessment examines the capabilities of major providers, focusing on their ability to deliver accurate, compliant, and actionable insights. Whether testing a new medical concept or monitoring brand health, understanding the nuances of panel recruitment, verification, and data security is essential for any insights director operating in this market.
Top Healthcare Market Research Panels in Russia: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Clinical development and market analytics | 81.5 |
| 2 | Top of Mind MR&C | Pharmaceutical brand health tracking | 74.5 |
| 3 | Global Vox Populi | Complex, multi-specialty healthcare professional research | 74.0 |
| 4 | OMI (Online Market Intelligence) | Physician opinion research | 74.0 |
| 5 | ICMR (GfK-Rus) | Retail and consumer behavior analysis | 65.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Healthcare professionals, patients, pharmacists, wholesalers | Not stated on pages reviewed | Not stated on pages reviewed | Not published | Not published | Not published |
| Top of Mind MR&C | Doctors, pharmacists, medical staff | Annual panelist validation | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, patients, payers, caregivers | License and registration records, rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 110,772 healthcare professionals; 48,041 nurses and allied health professionals; 1,284,147 patient profiles (in Russia; Global Vox Populi panel records, Oct 2026) | Not published |
| OMI (Online Market Intelligence) | Physicians, medical professionals | Diploma check and telephone verification | ESOMAR | Not published | 1 mln active participants (Total consumer panel) (omimr.com, Oct 2026) | Not published |
| ICMR (GfK-Rus) | General population, consumers | Not stated on pages reviewed | OIROM (Association of Market and Opinion Researchers) | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | ● |
| Top of Mind MR&C | ● | – | ● | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| OMI (Online Market Intelligence) | ● | ● | ● | ● | ● | – |
| ICMR (GfK-Rus) | ● | ● | ● | – | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to maintain data integrity and regulatory compliance in the specific context of Russian healthcare research.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This measures the origin of respondents and the rigor of identity and credential checks. In Russia, professionals must be validated against official registries or medical licenses. High scores reflect proprietary recruitment, while lower scores indicate reliance on open networks or self-reported data that lacks rigorous secondary confirmation. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO standards, local data protection laws, and industry codes. It is critical for managing sensitive health information. Top providers must demonstrate clear protocols for handling personal data and reporting adverse events according to established global guidelines like those from the BHBIA. |
| Target Audience Reach | 15 | This assesses the ability to access specific medical specialties, nurses, and patient groups. A provider must offer deep profiling beyond basic demographics. Success is determined by the depth of the available panel and the ability to find low-incidence cohorts within the unique Russian healthcare environment. |
| Data Quality and Fraud Prevention | 10 | This examines technical measures to filter out bots and fraudulent participants. Effective providers use device fingerprinting, geo-location verification, and trap questions. A strong score requires evidence of proactive, automated removal of low-quality completes before the data reaches the client for further analysis. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This tracks the range of research techniques offered, from simple online surveys to complex ethnography and qualitative interviews. A versatile provider supports various study types, including brand tracking, conjoint analysis, and in-depth expert interviews, providing the right tool for different stages of the product lifecycle. |
| Client Service and Speed | 5 | This reflects the provider's responsiveness and project management quality. In competitive markets, the speed of turnaround and the ability to handle fieldwork challenges are essential. High scorers provide clear, frequent communication and demonstrate flexibility in adapting to project-specific requirements as they emerge during fieldwork. |
| Pricing and Feasibility Transparency | 5 | This evaluates the clarity of project proposals and the accuracy of feasibility assessments. Providers must report realistic timelines and incidence rates. Transparency about what is achievable prevents project delays and makes sure that budgeting remains aligned with the actual complexity of the requested healthcare research. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare market research panels in Russia
IQVIA: best for clinical development and market analytics
Strongest fitLarge pharmaceutical organizations requiring comprehensive data-driven strategies for drug development and commercial launch.
IQVIA is a global entity that uses massive proprietary datasets to assist life sciences organizations. Its Russian operations focus on market insights, commercial effectiveness, and clinical trial management.
For buyers, IQVIA represents a high-end option for complex data-driven projects. Its capabilities span the entire product lifecycle, making it a suitable partner for large-scale strategic initiatives that require deep domain expertise and advanced analytics.
Scorecard: 81.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.5 |
Core services
- Market Insights & Analytics: Provides advanced analytics and market research to support commercial decision-making.
- Clinical Trial Solutions: Offers full-service clinical development solutions and site identification.
- Commercial Effectiveness: Helps organizations optimize their sales and marketing performance through data-driven insights.
Strengths
- Data Depth: Uses petabytes of proprietary data and non-identified patient records to drive insights.
- Global Expertise: Applies a global framework of healthcare-grade AI and analytics to local market challenges.
- Lifecycle Management: Supports pharmaceutical assets from clinical development through to commercial execution.
Innovation and technology
- IQVIA.ai Platform: A unified platform connecting data and analytics to accelerate decision-making.
Impact on businesses
- Strategic Optimization: Maximizes the probability of success for assets in competitive healthcare environments.
Why it may fit your brief
The firm excels in large-scale strategic projects involving massive datasets. For smaller, ad-hoc research needs, a more agile research agency might be more efficient and cost-effective.
Top of Mind MR&C: best for pharmaceutical brand health tracking
Strongest fitPharmaceutical brand managers and sales directors seeking to measure brand health and field force effectiveness.
Top of Mind specializes in healthcare and consumer insights, maintaining a large online medical panel in Russia. The firm provides a comprehensive set of tools designed specifically for the pharmaceutical and medical device industries.
Their service offering includes brand health tracking and performance checks for medical representatives. This focus allows the agency to provide highly relevant metrics to pharmaceutical brand managers looking to assess their market position and sales effectiveness.
Scorecard: 74.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | topofmind.ru (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 74.5 |
Core services
- Brand Health Tracking: Offers specialized tracking services to monitor brand performance and market position.
- Medical Representative Check: Provides tools to assess the performance of medical representatives in the field.
- Pricing Research: Conducts various pricing studies, including conjoint analysis and PSM methodology.
Strengths
- Healthcare Specialization: Deep focus on pharmaceutical and medical device research with specialized panels.
- Panel Validation: Conducts annual validation of panelists to maintain the accuracy of the medical database.
- Fast Turnaround: Offers express surveys designed to move from problem identification to solution in short timeframes.
Innovation and technology
- DocTrek and PharmTrek: Proprietary tracking tools for monitoring promotional activity and professional engagement.
Impact on businesses
- Commercial Performance: Helps pharmaceutical companies optimize their promotional efforts and pricing strategies.
Why it may fit your brief
The agency's dedicated pharmaceutical tools make it highly effective for ongoing brand tracking. Other firms might be better for ad-hoc qualitative studies or broad patient research.
Global Vox Populi: best for complex, multi-specialty healthcare professional research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitGlobal research teams and pharmaceutical brand managers needing verified, high-quality data from specific medical audiences in Russia.
Global Vox Populi maintains a significant footprint in the Russian market through its proprietary panels, which are built on direct recruitment and verification. By avoiding rented sample exchanges, the company maintains control over the entire research process, from initial contact to data delivery.
The firm is structured to support both quantitative and qualitative healthcare studies, with a strong emphasis on compliance and data integrity. Its approach is tailored to the specific needs of pharmaceutical and medical device companies requiring high-confidence data from hard-to-reach medical audiences.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Russia
110,772 panellists
- Primary & General46,514
- Internal Medicine Subspecialties9,288
- Acute, Peri-operative & Critical Care8,378
- Diagnostic & Laboratory7,670
- Women's & Reproductive Health7,540
- Surgical Specialties6,036
Nurses and allied health panel, in Russia
48,041 panellists
- Registered Nurses18,155
- Advanced Practice Nurses818
- Licensed / Practical / Enrolled Nurses3,385
- Nursing Support (Aides / HCAs)1,704
- Midwives1,144
- Pharmacists & Pharmacy Techs3,588
Patient panel, in Russia
1,284,147 patient profiles
- Aesthetics & Cosmetic411,483
- Cardiovascular105,703
- Ophthalmology72,125
- Endocrinology & Metabolic67,641
- Women's Health63,673
- Dermatology63,351
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Russia
1,745 panellists
- Provider: Access & Administrative Roles1,117
- Payer: Access & Coverage Roles628
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Healthcare Professional Research: Access to healthcare professionals across 70+ specialties, including surgeons, physicians, and specialists.
- Patient & Caregiver Studies: Comprehensive patient and caregiver research across multiple therapeutic areas and disease states.
- Payer & Provider Insights: Deep engagement with payers and providers to understand access and administrative dynamics.
- Nursing & Allied Health: Specialized nurses and allied health professionals panels for studies requiring non-physician medical perspectives.
Strengths
- Extensive Panel Depth: Managed panels include 110,772 healthcare professionals, 48,041 nursing staff, and 1,284,147 patient profiles in Russia.
- Rigorous Verification: Clinical members are validated against license and registration records, with re-validation performed on a rolling basis.
- Compliance Standards: Operations follow ISO 9001, ISO 20252, and ISO/IEC 27001 standards, protecting solid data handling and privacy.
Innovation and technology
- Proprietary Data Quality: Uses automated device fingerprinting, geo-location checks, and trap questions to eliminate bots and fraudulent completions.
- Mobile-First Methodology: Supports mobile and WhatsApp-assisted survey delivery to maximize participation among busy clinical staff.
Impact on businesses
- Strategic Decision Support: Delivers accurate data for product launches, market segmentation, and clinical pathway analysis.
- Adverse Event Management: Reports adverse events and product complaints according to BHBIA guidelines to protect full regulatory alignment.
Why it may fit your brief
The provider is well-suited for studies where the quality of the respondent is the primary driver of success. Other agencies may be preferred for general consumer research where healthcare specialization is not required.
OMI (Online Market Intelligence): best for physician opinion research
Strongest fitMarketing teams needing quick feedback from physicians or medical professionals on brand awareness and concept testing.
OMI is recognized for its dedicated MedMnenie panel, which was one of the first online medical panels established in Russia. The firm focuses on quantitative and qualitative online research for the pharmaceutical and healthcare sectors.
By recruiting from specialized medical sites and professional associations, OMI builds a panel motivated by professional growth as much as financial incentives. For researchers, this means access to a professional audience that is accustomed to participating in complex market studies.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | omimr.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Physician Online Panel: Operates the MedMnenie panel, a dedicated source for reaching physicians and medical professionals.
- Omnibus Surveys: Provides a rapid omnibus service for quick hypothesis testing and awareness measurement.
- Qualitative Support: Supports online qualitative research, including community management and respondent communication.
Strengths
- Medical Panel Specialization: The MedMnenie panel is specifically designed for marketing research with medical professionals.
- Verification Protocols: Professionals must pass verification by providing a diploma or participating in phone checks before panel entry.
- ESOMAR Adherence: The firm follows ESOMAR standards and provides documentation on its research methodologies.
Innovation and technology
- Omnibus Methodology: Enables rapid data collection through weekly waves, allowing for quick turnaround of research results.
Impact on businesses
- Decision Support: Provides high-quality data to marketing departments and advertising agencies for strategic planning.
Why it may fit your brief
The focus on professional growth for panelists makes this a strong choice for studies requiring engagement from busy doctors. Other firms may be better suited for large-scale patient or multi-specialty research.
ICMR (GfK-Rus): best for retail and consumer behavior analysis
Strongest fitCompanies looking for large-scale consumer purchasing data or retail environment analysis in Russia.
ICMR provides extensive retail and consumer panels, using 35 years of experience to deliver market insights. The firm focuses on consumer packaged goods and retail behavior, using mobile applications to track purchasing patterns.
While ICMR has a broad reach in the consumer space, its primary strength lies in its retail and HoReCa panels. For buyers, this firm is most effective when the research goal involves understanding broad consumer trends or out-of-home consumption rather than niche clinical specialties.
Scorecard: 65.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 5/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 6/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 6/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | icmr.ru (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 65.0 |
Core services
- Retail Panel Analytics: Provides deep analytics on the consumer market based on proprietary retail and consumer panels.
- HoReCa Research: Offers expert measurement of consumption in the public catering segment using a representative sample.
- Ad-hoc Research: Conducts specific, custom studies to identify market trends and support business decision-making.
Strengths
- Long-term Expertise: Operating since 1991, the firm offers deep institutional knowledge of the Russian consumer market.
- Technological Integration: Uses mobile applications and EAN-scanning to capture real-time consumer purchase data.
- Compliance Standards: Maintains quality standards aligned with the requirements of the Association of Market and Opinion Researchers (OIROM).
Innovation and technology
- Digital Data Capture: Employs an integrated mobile app to track daily purchases across over 200 retail and catering networks.
Impact on businesses
- Growth Strategy Support: Helps businesses identify market trends and make rapid decisions to drive growth.
Why it may fit your brief
This provider is ideal for understanding the consumer side of healthcare, such as over-the-counter medication purchasing patterns. It is less suitable for studies requiring deep clinical or medical professional expertise.
How HCP and patient verification actually works in Russia
Verify all medical credentials against official registries to confirm the professional standing of every panel member.
Credential Verification
For healthcare professionals, providers must cross-reference participant information with national medical registries or professional licenses. Always ask to see the specific protocol used for verifying a doctor's specialty and current practice status. Relying solely on self-reported data is a common source of error that can compromise the validity of your entire study.
Identity and Fraud Checks
Quality providers use multi-layered verification, including device fingerprinting and identity checks. During the screening process, ask for proof of how the provider filters out bots and duplicate accounts. A solid system will identify fraudulent attempts during the recruitment phase rather than after the data has been collected and analyzed.
Rolling Re-validation
Credentials change over time, and a panelist who was qualified a year ago may no longer be active in the same capacity. Inquire how often the provider re-validates the qualifications of its panel members. Regular, automated re-validation is a sign of a well-managed professional panel that takes data accuracy seriously.
Evidence of Compliance
Always request the provider's answers to the ESOMAR 37 questions for sample buyers. This document should detail their recruitment sources, verification methods, and data quality controls. If a provider cannot produce this or similar documentation, their panel quality may not meet the standards required for high-stakes pharmaceutical or clinical research in Russia.
How to choose the right provider in Russia
Select a provider based on the specific research objective and the required depth of professional expertise.
- Define project needs: Determine if your study requires broad consumer trends or niche clinical insights. Different providers prioritize either large-scale retail data or specialized medical panels.
- Review verification methods: Ask for specific details on how medical professionals are screened. Validating against licenses is necessary for high-quality professional insights.
- Assess panel ownership: Prioritize firms with proprietary panels to protect consistent quality. Rented samples often suffer from lower response rates and less reliable data.
- Check compliance standards: Protect the provider follows international research codes and local laws. This is essential for managing sensitive health data in the Russian Federation.
- Evaluate reporting capabilities: Confirm that the provider can handle adverse event reporting. This is a requirement for any pharmaceutical research project.
Questions to ask before you commission
- What is your specific protocol for verifying the medical credentials of your panelists in Russia?
- Do you own and manage your own panels, or do you rely on sample exchanges to fill project quotas?
- How often do you re-validate the professional status of your healthcare panelists?
- What specific technical controls do you use to detect and remove bots and fraudulent completions?
- Can you describe your process for reporting adverse events or product complaints during fieldwork?
- What is your typical turnaround time for a standard quantitative healthcare study in this market?
Common pitfalls to avoid
- Ignoring panel sources: Relying on aggregated sample lists instead of proprietary panels often leads to low-quality data and non-qualified respondents.
- Overlooking local regulation: Failing to account for local data protection laws and adverse event reporting requirements can lead to serious compliance issues.
- Assuming panel depth: Assuming a general research agency has access to niche medical specialists is a common error; always confirm the actual panel composition.
- Neglecting validation: Skipping secondary credential verification for medical professionals can result in data that lacks scientific credibility.
What a feasibility check should include
Conduct a formal feasibility check to make sure that the required sample size and respondent profile are achievable within your timeline.
Sample composition analysis
A proper check must confirm the exact number of active panelists available in the required medical specialty or patient group. This prevents delays caused by overestimating the reach of a panel.
Incidence rate estimation
The provider should provide a realistic assessment of the expected incidence rate based on historical project data. This makes sure your project budget and timeline are accurate from the start.
Timeline validation
Confirm that the proposed project duration is achievable given the recruitment and verification steps required. Realistic planning avoids the stress of rushed fieldwork.
Screening criteria review
Review your screening criteria with the provider to make sure they are clear and achievable. Overly restrictive criteria can make it impossible to reach the required sample size.
Conclusion
Choosing the right partner for healthcare market research panels in Russia requires a focus on panel ownership, credential verification, and regulatory compliance. For complex, multi-specialty research where data integrity is essential, providers with proprietary panels like Global Vox Populi offer the necessary rigor for high-stakes decision-making.
For more specific marketing needs, such as quick physician feedback or brand health tracking, specialized agencies like OMI or Top of Mind provide targeted tools and faster turnaround times. IQVIA remains the preferred choice for large-scale, data-driven projects that require integration with clinical development or commercial analytics. Use the scorecard to match your specific research goals with the strengths of these providers, making sure that your final selection supports the quality and reliability your business requires.
Planning research in Russia? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How to find healthcare market research panels in Russia?
To find reliable panels, start by identifying providers that maintain proprietary healthcare databases. Check if they are transparent about their recruitment sources and if they follow international standards like ESOMAR. It is essential to ask for their specific credential verification processes for physicians and other medical professionals to make sure the data you receive is from qualified sources.
Which companies provide physician panels for market research in Russia?
Several companies provide physician access, including Global Vox Populi, OMI, and Top of Mind. Each has different strengths; Global Vox Populi offers extensive multi-specialty reach, while OMI and Top of Mind focus on specific pharmaceutical marketing and tracking needs. Evaluate their panel size and verification methods to see which aligns best with your specific study requirements.
Are there specialized medical research panels for pharmacists in Russia?
Yes, specialized panels for pharmacists exist, often managed by healthcare-focused research agencies like Top of Mind and Global Vox Populi. These panels are typically recruited from professional associations and pharmacy networks. When selecting a provider, confirm that they have a sufficient number of pharmacists in their panel and that they follow strict verification protocols.
What are the best market research agencies for healthcare in Russia?
The best agency depends on your project goals. Global Vox Populi is well-suited for comprehensive, multi-specialty research; OMI and Top of Mind excel in pharmaceutical marketing and tracking; and IQVIA is ideal for large-scale, data-heavy projects. Assess your specific needs regarding panel depth, data analytics, and project scope before making a final choice.
How does healthcare market research operate in the Russian Federation?
Healthcare research in Russia involves strict adherence to local data protection laws and international ethical guidelines. It typically uses online panels for quantitative data and professional networks for qualitative work. All research must include clear consent protocols, and any pharmaceutical study must have procedures in place to report adverse events as required by global industry standards.
Are global research firms active in the Russian healthcare sector?
Yes, global firms such as IQVIA maintain a presence in Russia, providing specialized analytics and clinical research support. These firms often combine global methodology with local data expertise to serve large pharmaceutical and life sciences organizations. They are generally equipped to handle high-complexity projects that require deep domain knowledge and advanced technological integration.
What is the importance of credential verification in Russia?
Credential verification is the only way to make sure that your respondents are actual medical professionals. In a market where panel quality can vary, verifying licenses against official registries prevents non-qualified individuals from participating in surveys. This is critical for data accuracy and makes sure that your insights are based on professional medical opinion.
How are adverse events reported in Russian healthcare research?
Adverse events must be reported in accordance with the guidance set by the BHBIA and other international research bodies. Your chosen provider should have a clear, documented process for handling these reports during the fieldwork phase. Make sure this is explicitly discussed during the project scoping phase to maintain compliance and protect both the respondent and the client.